TEL AVIV, Israel--(BUSINESS WIRE)--Speaking at the 10th Annual Rodman & Renshaw Healthcare Conference in New York City today at 11:35 a.m. EST, Compugen Chairman Mr. Martin Gerstel presented a company overview focusing on the Company’s predictive biology based platforms for drug and diagnostic discovery and key aspects of the company’s operating and financial plans for calendar year 2009.
